Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-26

FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approves a supplemental application for a generic omeprazole and sodium bicarbonate product from Ajanta Pharma USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole and sodium bicarbonate (omeprazole and sodium bicarbonate)

Snippet

SUPPL AP for OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE AND SODIUM BICARBONATE)